TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multi-site, Randomized, Controlled Trial of a Mindfulness-based Cognitive Therapy Intervention for Treating Depression in a Traumatic Brain Injury Population.
Brief Summary: The purpose of this study is to determine whether mindfulness-based cognitive therapy is effective in reducing depression symptoms in individuals who have experienced a traumatic brain injury.

The investigators hypothesize that participants who are given the ten-week intervention will have fewer depression symptoms than the participants in the control group, and this improvement will be maintained at the three-month follow-up assessment.


Options:
A: Arm Label: Telephone-based CBT; Type: EXPERIMENTAL; Interventions: Behavioral: Telephone Cognitive Behavioral Therapy | Arm Label: In-person CBT; Type: EXPERIMENTAL; Interventions: Behavioral: In-person Cognitive Behavioral Therapy | Arm Label: 3: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: In-person Cognitive Behavioral Therapy; Assigned to Arm(s): In-person CBT | Intervention Type: BEHAVIORAL; Name: Telephone Cognitive Behavioral Therapy; Assigned to Arm(s): Telephone-based CBT
B: Arm Label: MBCT Intervention Group; Type: EXPERIMENTAL; Interventions: Behavioral: MBCT for TBI | Arm Label: MBCT Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: MBCT for TBI; Assigned to Arm(s): MBCT Intervention Group
C: Arm Label: Treatment Arm 1; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive behavioral therapy | Arm Label: Treatment Arm 2; Type: EXPERIMENTAL; Interventions: Behavioral: Supportive psychotherapy | Intervention Type: BEHAVIORAL; Name: Cognitive behavioral therapy; Assigned to Arm(s): Treatment Arm 1 | Intervention Type: BEHAVIORAL; Name: Supportive psychotherapy; Assigned to Arm(s): Treatment Arm 2
D: Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Scheduled telephone follow-up | Intervention Type: BEHAVIORAL; Name: Scheduled telephone follow-up; Assigned to Arm(s): 1

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial for Health Promotion/ Obesity Prevention Targeting Low-income, Urban, African-American Adolescents
Brief Summary: The purpose of Challenge! is to determine if adolescents enrolled in a health promotion/ obesity prevention program will have a healthier BMI-for-age z-score and body composition (body fat %), will consume a healthier diet, and engage in higher levels of physical activity compared to those that did not receive the intervention over time.


Options:
A: Intervention Type: BEHAVIORAL; Name: Fat and carbohydrate controlled diet; Assigned to Arm(s): N/A
B: Arm Label: Comparison Group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Parenting Program; Type: EXPERIMENTAL; Interventions: Behavioral: Parenting Program | Intervention Type: BEHAVIORAL; Name: Parenting Program; Assigned to Arm(s): Parenting Program
C: Arm Label: Non-overweight children in ball games program; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Ball games program | Arm Label: Overweight children in nutrition counseling program; Type: EXPERIMENTAL; Interventions: Behavioral: Nutrition counseling | Arm Label: Control group overweight children; Type: PLACEBO_COMPARATOR; Interventions: N/A | Arm Label: Overweight children in ball games program; Type: EXPERIMENTAL; Interventions: Behavioral: Ball games program | Arm Label: Overweight children in ball games and nutrition counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Ball games program, Behavioral: Nutrition counseling | Arm Label: Non-overweight control (no intervention); Type: PLACEBO_COMPARATOR; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Ball games program; Assigned to Arm(s): Non-overweight children in ball games program, Overweight children in ball games and nutrition counseling, Overweight children in ball games program | Intervention Type: BEHAVIORAL; Name: Nutrition counseling; Assigned to Arm(s): Overweight children in ball games and nutrition counseling, Overweight children in nutrition counseling program
D: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Challenge! | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Challenge!; Assigned to Arm(s): Intervention group

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial for Health Promotion/ Obesity Prevention Targeting Low-income, Urban, African-American Adolescents
Brief Summary: The purpose of Challenge! is to determine if adolescents enrolled in a health promotion/ obesity prevention program will have a healthier BMI-for-age z-score and body composition (body fat %), will consume a healthier diet, and engage in higher levels of physical activity compared to those that did not receive the intervention over time.


Options:
A: Arm Label: Park prescription; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Park prescription, Device: Pedometry | Arm Label: Park prescription and family outings; Type: EXPERIMENTAL; Interventions: Behavioral: Family outings, Behavioral: Park prescription, Device: Pedometry, Behavioral: Case Management | Intervention Type: BEHAVIORAL; Name: Family outings; Assigned to Arm(s): Park prescription and family outings | Intervention Type: BEHAVIORAL; Name: Park prescription; Assigned to Arm(s): Park prescription, Park prescription and family outings | Intervention Type: DEVICE; Name: Pedometry; Assigned to Arm(s): Park prescription, Park prescription and family outings | Intervention Type: BEHAVIORAL; Name: Case Management; Assigned to Arm(s): Park prescription and family outings
B: Intervention Type: BEHAVIORAL; Name: FLOW; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: SelfHelp; Assigned to Arm(s): N/A
C: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Challenge! | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Challenge!; Assigned to Arm(s): Intervention group
D: Arm Label: Physical activity intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Physical Activity | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Physical Activity; Assigned to Arm(s): Physical activity intervention group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 3, Placebo Controlled, Randomized, Double-blinded, Nonsteroidal Antiinflammatory Drug add-on Clinical Trial of Mono-phase Low Dose Oral Contraceptive Pill for Treatment of Primary Dysmenorrhea.
Brief Summary: The purpose of this study is to determine whether combination oral contraceptive pill of norethindrone and ethinyl estradiol is effective in the treatment of primary dysmenorrhea.


Options:
A: Arm Label: study group (CCOCP); Type: EXPERIMENTAL; Interventions: Drug: CCOCP | Arm Label: control group (traditional OCP); Type: ACTIVE_COMPARATOR; Interventions: Drug: Traditional OCP | Intervention Type: DRUG; Name: CCOCP; Assigned to Arm(s): study group (CCOCP) | Intervention Type: DRUG; Name: Traditional OCP; Assigned to Arm(s): control group (traditional OCP)
B: Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Qlarista Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: estradiol valerate/dienogest | Arm Label: Yasmin Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: ethinylestradiol and drospirenone | Intervention Type: DRUG; Name: estradiol valerate/dienogest; Assigned to Arm(s): Qlarista Group | Intervention Type: DRUG; Name: ethinylestradiol and drospirenone; Assigned to Arm(s): Yasmin Group
C: Arm Label: NOMAC-E2; Type: EXPERIMENTAL; Interventions: Drug: NOMAC-E2 | Arm Label: DRSP-EE; Type: ACTIVE_COMPARATOR; Interventions: Drug: DRSP-EE | Intervention Type: DRUG; Name: NOMAC-E2; Assigned to Arm(s): NOMAC-E2 | Intervention Type: DRUG; Name: DRSP-EE; Assigned to Arm(s): DRSP-EE
D: Arm Label: IKH-01; Type: EXPERIMENTAL; Interventions: Drug: IKH-01 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: IKH-01; Assigned to Arm(s): IKH-01 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase I, Open-Label, Randomized, Four Period Crossover Drug Interaction Study to Evaluate the Pharmacokinetic Profiles of VYVANSE™ and ADDERALL XR When Each is Administered Alone and in Combination With the Proton Pump Inhibitor Prilosec OTC™ in Healthy Adult Volunteers
Brief Summary: The purpose of this study is to determine if taking Vyvanse with Prilosec OTC or Adderall XR with Prilosec OTC changes how quickly the drug is absorbed into the body and/or changes how much of the drug is absorbed into the body.


Options:
A: Intervention Type: DRUG; Name: methylphenidate hydrochloride; Assigned to Arm(s): N/A
B: Arm Label: Vyvanse (LDX); Type: EXPERIMENTAL; Interventions: Drug: Lisdexamfetamine Dimesylate | Arm Label: Adderall XR (AXR); Type: EXPERIMENTAL; Interventions: Drug: Adderall XR (mixed salts amphetamine) | Intervention Type: DRUG; Name: Lisdexamfetamine Dimesylate; Assigned to Arm(s): Vyvanse (LDX) | Intervention Type: DRUG; Name: Adderall XR (mixed salts amphetamine); Assigned to Arm(s): Adderall XR (AXR)
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Adderall-XR 60 mg; Type: EXPERIMENTAL; Interventions: Drug: Adderall-XR | Arm Label: Adderall-XR 80 mg; Type: EXPERIMENTAL; Interventions: Drug: Adderall-XR | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Adderall-XR; Assigned to Arm(s): Adderall-XR 60 mg | Intervention Type: DRUG; Name: Adderall-XR; Assigned to Arm(s): Adderall-XR 80 mg
D: Arm Label: stimulant medication; Type: EXPERIMENTAL; Interventions: Drug: lisdexamfetamine | Arm Label: placebo pill; Type: PLACEBO_COMPARATOR; Interventions: Drug: lisdexamfetamine | Intervention Type: DRUG; Name: lisdexamfetamine; Assigned to Arm(s): placebo pill, stimulant medication

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Structured Contraceptive Counseling--A Randomized Controlled Trial
Brief Summary: In the United States, highly effective methods of birth control are often not used. Healthcare providers use birth control counseling and patient education as ways to increase the usage of birth control. However, little evidence exists to show that patient education and birth control counseling changes birth control use.

We want to evaluate the effectiveness of using a uniform set of birth control information to provide birth control education to women having an early pregnancy termination. The counselors will allow the clients to both read as well as hear the information. We propose to evaluate whether this counseling will lead to 1) more women choosing highly effective nonpermanent birth control methods and 2) more women continuing to use these methods for a longer time.

Women in the study will complete a questionaire about their health. Half of them will have the structured counseling and half will have the routine counseling currently offered to women as a part of their routine care. We will contact all study participants with a telephone call three months and six months later to have a 10 minute conversation about what birth control they are using.


Options:
A: Arm Label: 1 Standard Care (SC); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2 Standard Care + Educational (SCE); Type: OTHER; Interventions: Behavioral: educational instruction in clinic | Arm Label: 3 Standard Care + Educational + Phone Calls (SCEP); Type: OTHER; Interventions: Behavioral: educational instruction and phone follow-up | Intervention Type: BEHAVIORAL; Name: educational instruction and phone follow-up; Assigned to Arm(s): 3 Standard Care + Educational + Phone Calls (SCEP) | Intervention Type: BEHAVIORAL; Name: educational instruction in clinic; Assigned to Arm(s): 2 Standard Care + Educational (SCE)
B: Arm Label: EARLY; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing plus feedback | Arm Label: Video Information; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Video | Arm Label: Informational Brochure; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Informational Brochure | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing plus feedback; Assigned to Arm(s): EARLY | Intervention Type: BEHAVIORAL; Name: Video; Assigned to Arm(s): Video Information | Intervention Type: BEHAVIORAL; Name: Informational Brochure; Assigned to Arm(s): Informational Brochure
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Structured contraceptive counseling | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Structured contraceptive counseling; Assigned to Arm(s): 1
D: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Behavioral: follow-up phone counseling | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: follow-up phone counseling; Assigned to Arm(s): Treatment

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Can Simple and Inexpensive Techniques Enhance Patient Comfort in Sedation Risk-free Screening and Surveillance Colonoscopy?
Brief Summary: This research study compares two methods of performing colonoscopy without sedation. The standard method is to insert the colonoscope without adding any water to the colon, and when colonic spasms occur during the examination, waiting for the spasms to subside before continuing with the insertion of the colonoscope. The study method involves putting 200 ml (7 oz) of warm water through the colonoscope into the colon at the beginning of the examination, and when colonic spasms occur during the examination, putting 30 ml (1 oz) of warm water into the spastic area(s) to relax the colonic spasms.


Options:
A: Intervention Type: PROCEDURE; Name: water infusion colonoscopy; Assigned to Arm(s): N/A
B: Arm Label: Arm 1: Study Treatment; Type: EXPERIMENTAL; Interventions: Procedure: Colonoscopy | Arm Label: Arm 2: Control Treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Colonoscopy; Assigned to Arm(s): Arm 1: Study Treatment
C: Arm Label: Water infusion; Type: EXPERIMENTAL; Interventions: Procedure: Water infusion | Arm Label: Air insufflation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Air insufflation | Intervention Type: PROCEDURE; Name: Water infusion; Assigned to Arm(s): Water infusion | Intervention Type: PROCEDURE; Name: Air insufflation; Assigned to Arm(s): Air insufflation
D: Arm Label: air insufflation; Type: PLACEBO_COMPARATOR; Interventions: Procedure: air insufflation | Arm Label: water immersion; Type: ACTIVE_COMPARATOR; Interventions: Procedure: water immersion | Arm Label: water exchange; Type: ACTIVE_COMPARATOR; Interventions: Procedure: water exchange | Intervention Type: PROCEDURE; Name: air insufflation; Assigned to Arm(s): air insufflation | Intervention Type: PROCEDURE; Name: water immersion; Assigned to Arm(s): water immersion | Intervention Type: PROCEDURE; Name: water exchange; Assigned to Arm(s): water exchange

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Double-blind, Double-dummy, Randomised, Multi-centre, Comparative Phase III Clinical Study on the Efficacy and Tolerability of an 8 Week Oral Treatment With 9 mg Budesonide or 3 g Mesalazine in Patients With Active Ulcerative Colitis
Brief Summary: The purpose of this study is to prove the therapeutic equivalence and safety of once-daily 9 mg budesonide versus 3 g mesalazine in a 8-week treatment in patients with active ulcerative colitis.


Options:
A: Intervention Type: DRUG; Name: mesalazine; Assigned to Arm(s): N/A
B: Arm Label: TP05 (Mesalazine) 1600mg; Type: EXPERIMENTAL; Interventions: Drug: TP05 | Arm Label: Asacol 400 mg (Tillotts Pharma); Type: ACTIVE_COMPARATOR; Interventions: Drug: Asacol 400 mg | Intervention Type: DRUG; Name: TP05; Assigned to Arm(s): TP05 (Mesalazine) 1600mg | Intervention Type: DRUG; Name: Asacol 400 mg; Assigned to Arm(s): Asacol 400 mg (Tillotts Pharma)
C: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: budesonide | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: mesalazine | Intervention Type: DRUG; Name: budesonide; Assigned to Arm(s): A | Intervention Type: DRUG; Name: mesalazine; Assigned to Arm(s): B
D: Arm Label: Mesalazine once/day; Type: EXPERIMENTAL; Interventions: Drug: Mesalazine slow-release granules, Drug: Mesalazine liquid enema | Arm Label: Mesalazine twice/day; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mesalazine slow-release granules, Drug: Mesalazine liquid enema | Intervention Type: DRUG; Name: Mesalazine slow-release granules; Assigned to Arm(s): Mesalazine once/day, Mesalazine twice/day | Intervention Type: DRUG; Name: Mesalazine liquid enema; Assigned to Arm(s): Mesalazine once/day, Mesalazine twice/day

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Double-blind, Double-dummy, Randomised, Multi-centre, Comparative Phase III Clinical Study on the Efficacy and Tolerability of an 8 Week Oral Treatment With 9 mg Budesonide or 3 g Mesalazine in Patients With Active Ulcerative Colitis
Brief Summary: The purpose of this study is to prove the therapeutic equivalence and safety of once-daily 9 mg budesonide versus 3 g mesalazine in a 8-week treatment in patients with active ulcerative colitis.


Options:
A: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: budesonide | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: mesalazine | Intervention Type: DRUG; Name: budesonide; Assigned to Arm(s): A | Intervention Type: DRUG; Name: mesalazine; Assigned to Arm(s): B
B: Arm Label: Dersalazine; Type: EXPERIMENTAL; Interventions: Drug: Dersalazine sodium | Arm Label: Mesalazine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Mesalazine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Dersalazine sodium; Assigned to Arm(s): Dersalazine | Intervention Type: DRUG; Name: Mesalazine; Assigned to Arm(s): Mesalazine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: 1: budesonide-MMX® 6 mg; Type: EXPERIMENTAL; Interventions: Procedure: Blood sampling, endoscopy, Drug: budesonide-MMX® 6 mg | Arm Label: 2: budesonide-MMX® 9 mg; Type: EXPERIMENTAL; Interventions: Procedure: Blood sampling, endoscopy, Drug: budesonide-MMX® 9 mg | Arm Label: 3: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Blood sampling, endoscopy, Drug: Placebo | Arm Label: 4: Asacol® 400 mg; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Blood sampling, endoscopy, Drug: Asacol® 400 mg | Intervention Type: PROCEDURE; Name: Blood sampling, endoscopy; Assigned to Arm(s): 1: budesonide-MMX® 6 mg, 2: budesonide-MMX® 9 mg, 3: Placebo, 4: Asacol® 400 mg | Intervention Type: DRUG; Name: budesonide-MMX® 6 mg; Assigned to Arm(s): 1: budesonide-MMX® 6 mg | Intervention Type: DRUG; Name: budesonide-MMX® 9 mg; Assigned to Arm(s): 2: budesonide-MMX® 9 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 3: Placebo | Intervention Type: DRUG; Name: Asacol® 400 mg; Assigned to Arm(s): 4: Asacol® 400 mg
D: Arm Label: Mesalamin; Type: EXPERIMENTAL; Interventions: Drug: Mesalamin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Mesalamin | Intervention Type: DRUG; Name: Mesalamin; Assigned to Arm(s): Mesalamin, Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Double-blind, Double-dummy, Randomised, Multi-centre, Comparative Phase III Clinical Study on the Efficacy and Tolerability of an 8 Week Oral Treatment With 9 mg Budesonide or 3 g Mesalazine in Patients With Active Ulcerative Colitis
Brief Summary: The purpose of this study is to prove the therapeutic equivalence and safety of once-daily 9 mg budesonide versus 3 g mesalazine in a 8-week treatment in patients with active ulcerative colitis.


Options:
A: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: budesonide | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: mesalazine | Intervention Type: DRUG; Name: budesonide; Assigned to Arm(s): A | Intervention Type: DRUG; Name: mesalazine; Assigned to Arm(s): B
B: Arm Label: 1: budesonide-MMX® 6 mg; Type: EXPERIMENTAL; Interventions: Procedure: Blood sampling, endoscopy, Drug: Budesonide MMX® 6 mg | Arm Label: 2: budesonide-MMX® 9 mg; Type: EXPERIMENTAL; Interventions: Procedure: Blood sampling, endoscopy, Drug: Budesonide MMX® 9 mg | Arm Label: 3: Entocort EC® 3 mg; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Blood sampling, endoscopy, Drug: Entocort EC® 3 mg | Arm Label: 4: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Blood sampling, endoscopy, Drug: Placebo | Intervention Type: PROCEDURE; Name: Blood sampling, endoscopy; Assigned to Arm(s): 1: budesonide-MMX® 6 mg, 2: budesonide-MMX® 9 mg, 3: Entocort EC® 3 mg, 4: Placebo | Intervention Type: DRUG; Name: Budesonide MMX® 6 mg; Assigned to Arm(s): 1: budesonide-MMX® 6 mg | Intervention Type: DRUG; Name: Budesonide MMX® 9 mg; Assigned to Arm(s): 2: budesonide-MMX® 9 mg | Intervention Type: DRUG; Name: Entocort EC® 3 mg; Assigned to Arm(s): 3: Entocort EC® 3 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 4: Placebo
C: Intervention Type: DRUG; Name: Infliximab; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: Infliximab; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Intervention Program for Physically Inactive and Overweight Immigrant Women From the Middle East and Latin America Living in Sweden
Brief Summary: The purpose of this study is to improve and analyze the level of physical activity in immigrant women from the Middle East and Latin America living in Sweden. The investigators will also investigate if glucose, insulin, and lipid metabolism; stress-related hormone production; and subclinical inflammatory activity are affected by the intervention. The follow-up period is 2 years.


Options:
A: Arm Label: Life Style counseling (Star-Mama); Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Life Style Counseling (Star-Mama) | Arm Label: Educational Resource Support; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Life Style Counseling (Star-Mama); Assigned to Arm(s): Life Style counseling (Star-Mama)
B: Arm Label: Lay Health Worker Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Lay Health Worker Intervention | Arm Label: Placebo (a list of resources); Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Placebo (a list of resources) | Intervention Type: BEHAVIORAL; Name: Lay Health Worker Intervention; Assigned to Arm(s): Lay Health Worker Intervention | Intervention Type: BEHAVIORAL; Name: Placebo (a list of resources); Assigned to Arm(s): Placebo (a list of resources)
C: Arm Label: A; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Support for Increased Physical Activity | Intervention Type: BEHAVIORAL; Name: Support for Increased Physical Activity; Assigned to Arm(s): B
D: Arm Label: behavioral intervention, counseling; Type: EXPERIMENTAL; Interventions: Behavioral: culturally tailored diabetes education | Arm Label: delyed intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: culturally tailored diabetes education; Assigned to Arm(s): behavioral intervention, counseling

Answer: C